- Seed Round,
- Early stage VC,
- Later stage VC
The company focuses on biotech start-ups that develops technologies for the cystic fibrosis market, which consists of 30,000 patients in the United States and about 70,000 worldwide - numbers that pale in comparison to the cancer and heart disease markets.
- CompanyAmountRound
- Example example company Inc$ 1,000,000Investor meetings
- Company & Company€ 11,000,000Series C funding
- Example$ 524,000Seed round A
Email visible after logging in
Example Exampleexample
